West Pharmaceutical Services (MIL:1WST) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1WST West Pharmaceutical Services Inc MIL:1WST
69 GF Score
Price €305.80
GF Value €308.15
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is West Pharmaceutical Services FFO per Share?

FFO per Share only applies to REITs.

MIL:1WST
69GF Score
West Pharmaceutical Services Inc MIL:1WST
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is West Pharmaceutical Services (MIL:1WST) Overvalued in 2026?

Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued. The current stock price of €305.80 is trading 0.8% below its estimated GF Value™ of €308.15. GuruFocus considers West Pharmaceutical Services to be Fairly Valued.

Key valuation signals for MIL:1WST:

  • FFO per Share:
  • GF Value™: €308.15 vs. price of €305.80 (0.8% below fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the MIL:1WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


West Pharmaceutical Services Business Description

Address 530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
69GF Score

Get the complete analysis for MIL:1WST

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€305.80
Price
€308.15
GF Value